Matinas BioPharma Holdings, Inc. MTNB
Set alert
1.29 USD -0.22 -14.57%
At close
1.21 -0.08 -6.20%
Pre-market · Nov 3, 5:46 AM ET
0.97 Day range 1.54
0.97 52-week range 20.85
- YTD
- +120.14%
- 1 year
- -6.52%
- Open
- 1.49
- Prev close
- 1.51
- Mkt cap
- 1.26M
- Vol
- 224.16K
- Avg vol
- 91.27K
- EPS
- -17.55
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 0.97
- High
- 1.54
- Forward P/E
- -0.17
- Beta
- 1.73
- Short ratio
- 0.19
- Inst. own
- 26.08%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 1.38
- 200-d avg
- 6.37
- 1y target
- 0.00
Analyst view
Consensus: none
Price target (mean) 0.00
Ratings (0m) 2 0 buy · 2 hold · 0 sell
- Strong buy0
- Buy0
- Hold2
- Sell0
- Strong sell0
Recommendation trend
- This month 2
- 1 month ago 2
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.78 | -0.78 – -0.78 | -1.50 | +48.0% | 0 | 0.0% | 1 |
| Next quarter | 0.00 | 0.00 – 0.00 | -1.50 | 0.0% | 0 | 0.0% | 0 |
| Current year | -4.06 | -4.06 – -4.06 | -5.50 | +26.2% | 0 | -100.0% | 1 |
| Next year | -3.00 | -4.50 – -1.50 | -4.06 | +26.1% | 0 | 0.0% | 2 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 31, 2024 | Maxim Group | Downgrade | Buy | Hold |
| Jan 31, 2023 | HC Wainwright & Co. | Reiterated | — | Buy |
| Aug 13, 2020 | Aegis Capital | Maintained | — | Buy |
| Jan 27, 2020 | Piper Sandler | Initiated | — | Overweight |
| Jan 24, 2020 | SunTrust Robinson Humphrey | Initiated | — | Buy |
| Jun 26, 2019 | HC Wainwright & Co. | Initiated | — | Buy |
| May 17, 2019 | BTIG | Initiated | — | Buy |
| Feb 11, 2019 | Roth Capital | Initiated | — | Buy |
| Nov 13, 2018 | Maxim Group | Maintained | Buy | Buy |
| Aug 13, 2018 | Maxim Group | Maintained | Buy | Buy |
| Jul 10, 2018 | Maxim Group | Maintained | Buy | Buy |